Difficulty: Medium
Average Score: 73%
Practice
This drug is the preferred agent for teatment of nocardiosis and, in combination with pyrimethamine, is prophylactic against preumocystis carinii infections in AIDS patiens.
Correct answer
D
Rationale
In this NCLEX question on chemotherapy drugs, the correct answer is D) Sulfadiazine. Sulfadiazine is the preferred agent for the treatment of nocardiosis due to its efficacy against the causative agent, Nocardia. It is also used in combination with pyrimethamine as prophylaxis against Pneumocystis carinii infections in AIDS patients.
A) Ampicillin is a broad-spectrum antibiotic effective against many gram-positive and some gram-negative bacteria, but it is not the drug of choice for nocardiosis or Pneumocystis carinii prophylaxis.
B) Clindamycin is primarily used for anaerobic bacterial infections and is not the first-line treatment for nocardiosis or Pneumocystis carinii prophylaxis.
C) Norfloxacin is a fluoroquinolone antibiotic effective against certain bacterial infections, but it is not indicated for nocardiosis or Pneumocystis carinii prophylaxis.
Understanding the specific indications and mechanisms of action of different chemotherapy drugs is essential for successful management of infectious diseases. This question highlights the importance of knowing the appropriate drug choices for specific infections to provide optimal patient care.
A) Ampicillin is a broad-spectrum antibiotic effective against many gram-positive and some gram-negative bacteria, but it is not the drug of choice for nocardiosis or Pneumocystis carinii prophylaxis.
B) Clindamycin is primarily used for anaerobic bacterial infections and is not the first-line treatment for nocardiosis or Pneumocystis carinii prophylaxis.
C) Norfloxacin is a fluoroquinolone antibiotic effective against certain bacterial infections, but it is not indicated for nocardiosis or Pneumocystis carinii prophylaxis.
Understanding the specific indications and mechanisms of action of different chemotherapy drugs is essential for successful management of infectious diseases. This question highlights the importance of knowing the appropriate drug choices for specific infections to provide optimal patient care.